Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5827044 | European Journal of Pharmacology | 2015 | 8 Pages |
Abstract
Isometrically mounted segments of mouse distal tail artery were used to investigate the effects of endothelium denudation, blocking Ca2+ channels and inhibiting superoxide signalling on Ang II-induced facilitation of nerve-evoked contractions. In addition, in situ amperometry was used to assess effects of Ang II on noradrenaline release. Ang II (0.1-1 nM) increased nerve-evoked contractions but did not change noradrenaline release. Losartan (Ang II type 1 receptor antagonist), but not PD 123319 (Ang II type 2 receptor antagonist), blocked the facilitatory effect of Ang II on nerve-evoked contractions. Ang II increased vascular muscle reactivity to phenylephrine and UK-14304 (α1- and α2-adrenoceptor agonists, respectively). Endothelial denudation increased nerve-evoked contractions and reduced the facilitatory effect of Ang II on these responses. Efonidipine (L- and T-type Ca2+ channel blocker) and NNC 55-0396 (T-type Ca2+ channel blocker) also attenuated this effect of Ang II, while nifedipine (L-type Ca2+ channel blocker) did not. Blockers of superoxide generation/signalling did not change the facilitatory effect of Ang II on nerve-evoked contractions. The findings indicate that Ang II increases the contribution of T-type Ca2+ channels to neural activation of the vascular muscle. In addition, Ang II appears to reduce the inhibitory influence of the endothelium on nerve-evoked contractions.
Keywords
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Trent F. Reardon, Brid P. Callaghan, James A. Brock,